4,7,10,13-eicosatetraynoic acid has been researched along with masoprocol in 3 studies
| Studies (4,7,10,13-eicosatetraynoic acid) | Trials (4,7,10,13-eicosatetraynoic acid) | Recent Studies (post-2010) (4,7,10,13-eicosatetraynoic acid) | Studies (masoprocol) | Trials (masoprocol) | Recent Studies (post-2010) (masoprocol) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 1,527 | 8 | 163 |
| Protein | Taxonomy | 4,7,10,13-eicosatetraynoic acid (IC50) | masoprocol (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3.5 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parthasarathy, S; Steinberg, D; Wieland, E | 1 |
| Kishore, NP; Rao, GH; White, JG | 1 |
| Knepel, W; Vlaskovska, M | 1 |
3 other study(ies) available for 4,7,10,13-eicosatetraynoic acid and masoprocol
| Article | Year |
|---|---|
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aorta; Aspirin; Cells, Cultured; Copper; Endothelium, Vascular; Humans; Indomethacin; Lipoproteins, LDL; Lipoxygenase; Masoprocol; Oxidation-Reduction; Rabbits; Recombinant Proteins; Superoxide Dismutase; Superoxides | 1989 |
Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Adult; Arachidonate Lipoxygenases; Blood Platelets; Cell Membrane; Cytosol; Humans; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Prostaglandin Antagonists; Pyrazoles; Quercetin; Substrate Specificity; Umbelliferones | 1987 |
Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Adrenocorticotropic Hormone; Animals; Arachidonic Acids; beta-Endorphin; Catechols; Dinoprostone; Endorphins; In Vitro Techniques; Indomethacin; Male; Masoprocol; Pituitary Gland, Anterior; Prostaglandins E; Pyrazoles; Rats; Rats, Inbred Strains | 1984 |